BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 3977490)

  • 1. Persistence of abnormal RBC and platelet phenotype during recovery from aplastic anemia.
    Bessman JD; Gardner FH
    Arch Intern Med; 1985 Feb; 145(2):293-6. PubMed ID: 3977490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trilineage recovery by combination therapy with recombinant human granulocyte colony-stimulating factor and erythropoietin in patients with aplastic anemia and refractory anemia.
    Bessho M; Jinnai I; Hirashima K; Saito M; Murohashi I; Ino H; Tsuji M; Fukuda M; Maruyama M; Kusumoto S
    Stem Cells; 1994 Nov; 12(6):604-15. PubMed ID: 7533579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A phase I/II study of interleukin-3 in patients with aplastic anemia and myelodysplasia.
    Nimer SD; Paquette RL; Ireland P; Resta D; Young D; Golde DW
    Exp Hematol; 1994 Aug; 22(9):875-80. PubMed ID: 8062886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet size and shape in hereditary giant platelet syndromes on blood smear and in suspension: evidence for two types of abnormalities.
    Milton JG; Hutton RA; Tuddenham EG; Frojmovic MM
    J Lab Clin Med; 1985 Sep; 106(3):326-35. PubMed ID: 4031633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colony growth in cultures from bone marrow and peripheral blood after curative treatment for leukemia and severe aplastic anemia.
    Betticher DC; Huxol H; Müller R; Speck B; Nissen C
    Exp Hematol; 1993 Nov; 21(12):1517-21. PubMed ID: 8405233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peripheral blood picture in primary hypocellular refractory anemia and idiopathic acquired aplastic anemia: an additional tool for differential diagnosis.
    Elghetany MT; Hudnall SD; Gardner FH
    Haematologica; 1997; 82(1):21-4. PubMed ID: 9107077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of serum thrombopoietin levels by platelets and megakaryocytes in patients with aplastic anaemia and idiopathic thrombocytopenic purpura.
    Ichikawa N; Ishida F; Shimodaira S; Tahara T; Kato T; Kitano K
    Thromb Haemost; 1996 Aug; 76(2):156-60. PubMed ID: 8865522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of known hepatitis virus in hepatitis-associated aplastic anemia and outcome after bone marrow transplantation.
    Safadi R; Or R; Ilan Y; Naparstek E; Nagler A; Klein A; Ketzinel-Gilaad M; Ergunay K; Danon D; Shouval D; Galun E
    Bone Marrow Transplant; 2001 Jan; 27(2):183-90. PubMed ID: 11281388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Correlations between parameters characterizing the volume and number of erythrocytes and platelets in human blood].
    Matiushichev VB; Shamratova VG; Khidiiatov II
    Fiziol Cheloveka; 2004; 30(3):136-9. PubMed ID: 15344719
    [No Abstract]   [Full Text] [Related]  

  • 10. Congenital hypoplastic anemia.
    Diamond LK; Wang WC; Alter BP
    Adv Pediatr; 1976; 22():349-78. PubMed ID: 773132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet size deviation width, platelet large cell ratio, and mean platelet volume have sufficient sensitivity and specificity in the diagnosis of immune thrombocytopenia.
    Kaito K; Otsubo H; Usui N; Yoshida M; Tanno J; Kurihara E; Matsumoto K; Hirata R; Domitsu K; Kobayashi M
    Br J Haematol; 2005 Mar; 128(5):698-702. PubMed ID: 15725092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Thrombocyte substitution in hematologic patients].
    Wiesneth M
    Beitr Infusionsther; 1993; 31():86-91. PubMed ID: 7693270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multilineage response in aplastic anemia patients following long-term administration of filgrastim (recombinant human granulocyte colony stimulating factor).
    Sonoda Y; Ohno Y; Fujii H; Takahashi T; Nakayama S; Haruyama H; Nasu K; Shimazaki C; Hara H; Kanamaru A
    Stem Cells; 1993 Nov; 11(6):543-54. PubMed ID: 7509223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum stem cell factor levels in patients with aplastic anemia.
    Nimer SD; Leung DH; Wolin MJ; Golde DW
    Int J Hematol; 1994 Oct; 60(3):185-9. PubMed ID: 7532030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors influencing platelet survival during antilymphocyte globulin treatment.
    Gratama JW; Brand A; Jansen J; Zwaan FE; Valentijn RM; Eernisse JG
    Br J Haematol; 1984 May; 57(1):5-15. PubMed ID: 6722037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A simple technique to determine thrombopoiesis level using immature platelet fraction (IPF).
    Abe Y; Wada H; Tomatsu H; Sakaguchi A; Nishioka J; Yabu Y; Onishi K; Nakatani K; Morishita Y; Oguni S; Nobori T
    Thromb Res; 2006; 118(4):463-9. PubMed ID: 16253312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Erythrocyte longevity in hypoplastic anemia patients undergoing splenectomy as part of combined treatment].
    Rakhmatullaev AR; Karitskaia GK
    Ter Arkh; 1987; 59(9):98-101. PubMed ID: 3424200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet volume is not increased in essential hypertension.
    Bath PM; Carney C; Markandu ND; MacGregor GA
    J Hum Hypertens; 1994 Jun; 8(6):457-9. PubMed ID: 8089831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of severe aplastic anemia with antithymocyte globulin.
    Rothmann SA; Streeter RR; Bukowski RM; Hewlett JS
    Exp Hematol; 1982 Oct; 10(9):809-16. PubMed ID: 6983454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hematopoietic stem cell transplantation for high-risk adult patients with severe aplastic anemia; reduction of graft failure by enhancing stem cell dose.
    Min CK; Kim DW; Lee JW; Han CW; Min WS; Kim CC
    Haematologica; 2001 Mar; 86(3):303-10. PubMed ID: 11255278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.